| Time | Session |
|---|
|
10:45
20:00
|
Nanobodies against PSMA as the foundation for new tracers for prostate cancer imaging and treatment
P-495
EACR25-0109
Tong Yang
Poster Presenter
Netherlands
|
Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation
P-497
EACR25-0203
Hong Seok Kim
Poster Presenter
Korea (Republic of)
|
Exercise to boost the immune system and optimise immunotherapy responsiveness in pancreatic cancer
P-498
EACR25-0279
Brindley Hapuarachi
Poster Presenter
United Kingdom
|
Epigenetic Modulation of CAR-T cells against Group 3 Medulloblastoma
P-499
EACR25-0289
Song San Chan
Poster Presenter
United Kingdom
|
Unveiling interactions between senescent tumor cells and the host immune system - Implications for Senolytic Immunotherapy
P-500
EACR25-0347
Bartolomeo Bosco
Poster Presenter
Germany
|
Investigating the repurposing potential of immune checkpoint inhibitors to additional cancer patient populations using Mendelian randomisation
P-501
EACR25-0435
Tessa Bate
Poster Presenter
United Kingdom
|
Assessing the Potential of Epigenetic Inhibitors to Improve Immunotherapy Response via In Vitro Models
P-502
EACR25-0481
Manuel Pino Gonz
Poster Presenter
Spain
|
Bacterial Endospores as Antigen Carriers: A Novel Strategy for Cancer Vaccines
P-901
EACR25-0671
Lourenço Cayolla Bonneville
Poster Presenter
Italy
|
Next Generation Protein Characterization of CD19-CAR Signaling Cascades
P-503
EACR25-0825
Warren Higgs
Poster Presenter
United Kingdom
|
The effect of STING agonist on lung metastases and immune landscape in murine model of spontaneous breast cancer metastasis
P-504
EACR25-0955
Alina Drzyzga
Poster Presenter
Poland
|
Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform
P-505
EACR25-1001
Paola Genevini
Poster Presenter
Italy
|
Understanding bystander killing by bispecific monoclonal antibodies
P-506
EACR25-1143
May Sin Ke
Poster Presenter
United Kingdom
|
A novel synthetic peptide HS1002 Enhances T Cell-Mediated Antitumor Immunity
P-507
EACR25-1203
Jae Hyeon Park
Poster Presenter
Korea (Republic of)
|
Induction of TWIST1-specific antitumor immunity by DNA vaccine encoding a truncated TWIST1 antigen
P-508
EACR25-1425
Zhiwu Tan
Poster Presenter
Hong Kong, China
|
mRNA Cancer Vaccines: Leveraging Sugar-Functionalized LNPs for Targeted Antitumor Immunity
P-509
EACR25-1491
Jo
Poster Presenter
Portugal
|
Characterization of radiolabelled single-domain anti-HER2 antibodies as potential radioimmunotherapeutics for breast cancer
P-510
EACR25-1577
Zuzanna Napora
Poster Presenter
Poland
|
Glycopolymer-Mediated Gene Delivery for Efficient CAR-T Cell Production
P-511
EACR25-1641
Diana Pinheiro Correia
Poster Presenter
Portugal
|
Cellular Composition and Dynamics Upon Immunotherapy Correlate with Clinical Response
P-512
EACR25-1649
Zhongyang Lin
Poster Presenter
Israel
|
Redox-Responsive Self-Immolative Nanogels for Cellular Immunotherapies
P-513
EACR25-1671
Diana Pinheiro Correia
Poster Presenter
Portugal
|
Development of PD-L1 based cancer vaccine conjugating a novel T cell epitope
P-514
EACR25-1699
Tomoyuki Nishikawa
Poster Presenter
Japan
|
Selection and identification of nanobodies against a cancer-testis antigen, placenta-specific protein 1
P-515
EACR25-1757
Phakjira Tiraratchailert
Poster Presenter
Thailand
|
Patient-derived tumor tissue cultures (PDTTCs) as a new platform for assessing T cell engager efficacy in glioblastoma.
P-516
EACR25-1815
Raffaella Iurlaro
Poster Presenter
Spain
|
ENO3PEP vaccine enhances chemotherapy efficacy in pancreatic cancer by boosting anti-tumor immunity
P-517
EACR25-1817
Silvia Brugiapaglia
Poster Presenter
Italy
|
Enhanced natural killer cell anti-tumor activity with Erastin mediated ferroptosis and potential therapeutic application in neuroblastoma.
P-518
EACR25-1823
Ganesh Umapathy
Poster Presenter
Sweden
|
An innovative immune-on-chip platform for studying tumor-immune interactions and evaluating novel immunomodulatory therapies
P-519
EACR25-1849
SILVIA SCAGLIONE
Poster Presenter
|
MicroRNAs humoral and cellular immune response profile to COVID-19 vaccine boost in cancer patients
P-907
EACR25-1881
Tânia Rôlo Dias
Poster Presenter
Portugal
|
The immune and metabolic profile in metastatic and early-stage triple negative breast cancer patients treated with immune checkpoint inhibitors.
P-520
EACR25-1935
Luc
Poster Presenter
Spain
|
Exploring CAR-T Cell Killing Dynamics Through Live-Cell Fluorescence Microscopy
P-521
EACR25-1965
Svenja Meiler
Poster Presenter
|
Characterization of Different CAR Architectures Harboring the Murine GD2 Binder 14G2a
P-521A
EACR25-1987
Ines del Rincon
Poster Presenter
Germany
|
Cytotoxic ILC-1 cells determine outcome of PD-(L)1 blockade in microsatellite instable cancers
P-522
EACR25-2039
Paula Van Royen
Poster Presenter
Netherlands
|
Visualization and quantification of antibody-dependent cellular phagocytosis (ADCP) using a live-cell imaging high-throughput automation system
P-523
EACR25-2051
Reinhild Geisen
Poster Presenter
Germany
|
Distinct chemotherapy regimens differentially modulate the immune landscape of triple-negative breast cancer, with potential impact on combination with immunotherapy
P-524
EACR25-2225
Marco Barreca
Poster Presenter
Italy
|
Inhibition of Furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities
P-525
EACR25-2299
Lydia Ziane Chaouche
Poster Presenter
France
|
A positive crosstalk between chemokine receptor CXCR4 and intrinsic programmed cell death-1 receptor (iPD-1): anti PD-1, nivolumab, impairs CXCL12-induced signaling, proliferation and migration in human colon cancer cells
P-526
EACR25-2311
Caterina Ieran
Poster Presenter
Italy
|
Combining NK/CAR-NK-based therapy with autophagy inhibition as therapeutic strategy in high-risk medulloblastoma
P-527
EACR25-2321
Manuela Giansanti
Poster Presenter
Italy
|
Anti-IL-7Rα antibodies: a targeted therapy for T-cell Acute Lymphoblastic Leukemia
P-528
EACR25-2349
Mafalda Dias Duque
Poster Presenter
Portugal
|
Improving Triple-Negative Breast Cancer immunogenicity via viral-mediated epigenetic remodeling
P-529
EACR25-2457
Salvatore Russo
Poster Presenter
Finland
|
Advancing CAR-T clinical development with high-parameter CyTOF technology
P-530
EACR25-2549
Melissa Klug
Poster Presenter
|